Medical technology firm Hologic has been granted clearance from the FDA to market its Genius Digital Diagnostics System, powered by the company's Genius Cervical AI algorithm.
The digital cytology system – a medical diagnostic tool used to examine cells under a microscope to detect abnormalities or diseases – integrates deep learning-based AI with advanced volumetric imaging technology to aid in...
Cancer detection technology startup Adela announced it secured $48 million in funding, bringing its total raise to $108 million.
Labcorp joined the round as a new investor alongside existing investors OrbiMed, Decheng Capital, F-Prime Capital, Deerfield Management and RA Capital Management.
Adela also named Lisa Alderson as its interim CEO. Alderson has served on the company's board of...
South Korean AI company Lunit has tied up with its investor, Guardant Health, for AI integration.
Under the partnership, Lunit will integrate its PD-L1 scoring algorithm into Guardant's cancer biomarker detection workflow in the Guardant360 TissueNextTM PD-L1 test for non-small cell lung cancer (NSCLC).
Lunit SCOPE PD-L1, a CE-marked AI solution, detects and analyses PD-L1, a type of cancer...
Researchers from the Indian Institute of Technology in Madras have come up with a new AI prediction tool that can detect cancer-causing genes in individuals.
WHAT IT DOES
Dubbed PIVOT, the AI tool is based on a prediction model that uses information on mutations, expression of genes, and copy number variation in genes and perturbations in the biological network due to an altered gene expression....
The NHS today announced it is launching the world’s largest trial of a blood test which can detect more than 50 types of cancer before symptoms appear.
Research has shown the Galleri test is effective at finding cancers that are typically difficult to identify early, including head and neck, bowel, lung, pancreatic, and throat cancers.
It works by finding chemical changes in fragments of genetic...
Ibex Medical Analytics, an Israel-based startup using artificial intelligence to support cancer diagnostics, has unveiled a $38 million Series B funding round. Octopus Ventures and 83North led the raise, which also saw participation from aMoon, Planven Entrepreneur Ventures and Dell Technologies Capital.
WHAT IT DOES
Ibex's Galen platform uses AI and machine learning to reduce the burden on...
MicroRNA (MiRNA) is a small RNA molecule that play a central part in the functioning of the human body and are promising markers for identifying the early-stage risk of diseases such as cancer. According to an article published in Clinical Epigenetics in 2018, the differential expression of circulating miRNAs exhibited promising potential for cancer screening without additional injury for...
Ark, a Singapore-based medtech enterprise focused on early cancer detection, has raised a record US$40 million in Series A funding. Ark’s vision is “a world without late-stage cancer” and its mission is to eliminate late-stage cancer related death by 2048 through the introduction of accurate, affordable, and actionable cancer detection technologies. This record-breaking Series A round was led by...
Alexander Börve’s company FirstDerm offers online consultations with board-certified dermatologists and a free product that uses AI to give users ideas about what their skin condition might be. But Börve’s background isn’t in dermatology. In fact he’s an orthopedic surgeon by training. He had the idea to build his app because he realized how pervasive the need is for dermatological consultation...
The British government is now turning to artificial intelligence as an avenue for early cancer and chronic disease detection. This morning, Prime Minister Theresa May announced plans to invest in AI technology development for the healthcare sector as part of her industrial strategy. The plans aim not only to improve healthcare but to grow the country's AI industry.
“The UK will use data,...
